KMDA Key Statistics, Chart & Performance
The current stock price of KMDA is 7.92 USD. In the past month the price increased by 12.02%. In the past year, price increased by 10.15%.
KMDA Technical Analysis
ChartMill assigns a technical rating of 8 / 10 to KMDA. When comparing the yearly performance of all stocks, KMDA is one of the better performing stocks in the market, outperforming 74.85% of all stocks.
KMDA Fundamental Analysis
ChartMill assigns a fundamental rating of 6 / 10 to KMDA. While KMDA belongs to the best of the industry regarding profitability, there are some minor concerns on its financial health.
KMDA Financial Highlights
Over the last trailing twelve months KMDA reported a non-GAAP Earnings per Share(EPS) of 0.36. The EPS increased by 28.57% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 11.7% | ||
| ROA | 5.42% | ||
| ROE | 7.72% | ||
| Debt/Equity | 0.04 |
KMDA Forecast & Estimates
9 analysts have analysed KMDA and the average price target is 13.26 USD. This implies a price increase of 67.42% is expected in the next year compared to the current price of 7.92.
For the next year, analysts expect an EPS growth of 44.17% and a revenue growth 12.37% for KMDA
KMDA Ownership
About KMDA
Company Profile
Kamada Ltd. is a biopharmaceutical company, which focuses on specialty plasma-derived therapeutic. The firm uses its proprietary platform technology and know-how for the extraction and purification of proteins from human plasma to produce Alpha-1 Antitrypsin (AAT) in a highly-purified, liquid form, as well as other plasma-derived Immune globulins.
Company Info
KAMADA LTD
2 Holtzman St., Science Park
Rehovot 7670402 IL
CEO: Amir London
Employees: 374
Phone: 97289406472
KAMADA LTD / KMDA FAQ
Can you describe the business of KAMADA LTD?
Kamada Ltd. is a biopharmaceutical company, which focuses on specialty plasma-derived therapeutic. The firm uses its proprietary platform technology and know-how for the extraction and purification of proteins from human plasma to produce Alpha-1 Antitrypsin (AAT) in a highly-purified, liquid form, as well as other plasma-derived Immune globulins.
What is the current price of KMDA stock?
The current stock price of KMDA is 7.92 USD. The price decreased by -0.75% in the last trading session.
What is the dividend status of KAMADA LTD?
KAMADA LTD (KMDA) has a dividend yield of 2.53%. The yearly dividend amount is currently 0.
How is the ChartMill rating for KAMADA LTD?
KMDA has a ChartMill Technical rating of 8 out of 10 and a ChartMill Fundamental rating of 6 out of 10.
Which stock exchange lists KMDA stock?
KMDA stock is listed on the Nasdaq exchange.
Can you provide the market cap for KAMADA LTD?
KAMADA LTD (KMDA) has a market capitalization of 456.83M USD. This makes KMDA a Small Cap stock.
What is the ownership structure of KAMADA LTD (KMDA)?
You can find the ownership structure of KAMADA LTD (KMDA) on the Ownership tab.